There are two types of herpes simplex virus: HSV-1 and HSV-2. Both cause lifelong infections, both produce similar-looking sores, and both live inside nerve cells where they cycle between inactive and active states. The key differences come down to where they prefer to cause symptoms, how they spread, and how often they flare up.
HSV-1: The Oral Type
HSV-1 is the more common of the two. It spreads primarily through oral contact and causes infections in or around the mouth, commonly known as cold sores or fever blisters. Most people pick it up during childhood from a kiss or shared utensil, often without realizing it.
HSV-1 can also cause genital herpes, typically through oral sex. An estimated 376 million people worldwide had genital HSV-1 infections as of 2020. This crossover is a major reason the old shorthand of “HSV-1 equals oral, HSV-2 equals genital” no longer holds up. If you have genital herpes, either type could be responsible, and knowing which one matters because the two behave differently below the waist.
HSV-2: The Genital Type
HSV-2 spreads through sexual contact and almost exclusively causes genital infections. Around 520 million people aged 15 to 49 were living with genital HSV-2 in 2020, putting the total number of adults with some form of genital herpes at over 846 million, or roughly one in five people in that age group worldwide.
Women are infected with HSV-2 nearly twice as often as men because the virus transmits more efficiently from men to women during sex. You can carry both types at the same time. Of the 376 million people with genital HSV-1, an estimated 50 million also had HSV-2.
How the Two Types Behave Differently
The biggest practical difference is recurrence. HSV-2 causes significantly more frequent outbreaks when it infects the genitals compared to genital HSV-1. If you’re diagnosed with genital herpes caused by HSV-1, you can generally expect fewer and less severe flare-ups over time. Genital HSV-2, on the other hand, tends to reactivate more often, especially in the first year or two after infection.
Asymptomatic shedding, where the virus is present on the skin without any visible sores, also differs between the two. HSV-2 sheds more frequently than HSV-1 in the genital area. This matters because an estimated 70% of herpes transmissions happen during these invisible shedding periods, not during obvious outbreaks. Shedding is most frequent closer to the time you first acquire the infection and tapers off over the years, though it never stops entirely.
Symptoms and What to Expect
Both types produce the same general symptoms: clusters of small, painful blisters that break open, crust over, and heal. For oral herpes, these appear on or around the lips. For genital herpes, they show up on the genitals, buttocks, or thighs. Many people experience tingling or itching in the area before sores appear.
A first outbreak is usually the worst. It can include flu-like symptoms such as fever, body aches, and swollen lymph nodes alongside the sores. Recurrent outbreaks are typically milder and shorter. A large percentage of people with herpes, particularly HSV-1, never develop noticeable symptoms at all and have no idea they carry the virus.
How Each Type Is Diagnosed
If you have active sores, the most accurate test is a nucleic acid amplification test (NAAT) taken directly from the lesion. This is more sensitive than the older method of viral culture and can distinguish between HSV-1 and HSV-2. When no sores are present, a type-specific blood test can detect antibodies to each virus separately. These blood tests are 80% to 98% sensitive for HSV-2, but accuracy drops if you test too early. If you think you were recently exposed, testing at least 12 weeks after the potential exposure gives the most reliable result.
Potential Complications
For most people, herpes is a manageable skin condition. Serious complications are uncommon but worth knowing about.
HSV-2 occasionally causes viral meningitis, an inflammation of the membranes surrounding the brain and spinal cord. This affects roughly 2.2 people per 100,000, and among those who develop meningitis with a first HSV-2 infection, 20% to 30% experience recurrent episodes. These episodes are painful and disruptive but rarely life-threatening in adults with healthy immune systems.
The most serious risk involves newborns. Neonatal herpes occurs in about 10 out of every 100,000 live births globally, totaling an estimated 14,000 cases per year. HSV-2 accounts for roughly 10,000 of those cases and HSV-1 for about 4,000. Without treatment, neonatal herpes has an estimated fatality rate of 60%, which is why screening and precautions during delivery are critical for pregnant women with herpes.
Managing Herpes Long Term
Antiviral medications can shorten outbreaks, reduce their severity, and lower the chance of transmitting the virus to a partner. For people with frequent recurrences, daily suppressive therapy keeps the virus less active and reduces both visible outbreaks and asymptomatic shedding. These medications don’t cure the infection, but they make a meaningful difference in quality of life and transmission risk.
Because the virus lives permanently in nerve cells, it reactivates periodically throughout your life. The good news is that outbreaks generally become less frequent and less intense over the years as your immune system builds a stronger response to the virus. Many people find that after the first year or two, herpes becomes a minor, infrequent inconvenience rather than a constant concern.